Related Experiment Video
Updated: Mar 17, 2026

08:17
A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
15.6K
An open-label phase I dose-finding study of APR-246 in hematological malignancies
S Deneberg1, H Cherif2, V Lazarevic3
1Karolinska University Hospital, Center of Hematology and Karolinska Institutet, Institution of Medicine, Huddinge, Sweden.
Blood Cancer Journal
|July 16, 2016
Summary
No abstract available in PubMed .

